410 related articles for article (PubMed ID: 29220615)
1. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
McElrath K; Joseph H
Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
[TBL] [Abstract][Full Text] [Related]
2. Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
McElrath K
Subst Use Misuse; 2018 Jan; 53(2):334-343. PubMed ID: 28862903
[TBL] [Abstract][Full Text] [Related]
3. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
Trigg BG; Dickman SL
Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
[TBL] [Abstract][Full Text] [Related]
4. Intervention stigma: How medication-assisted treatment marginalizes patients and providers.
Madden EF
Soc Sci Med; 2019 Jul; 232():324-331. PubMed ID: 31125801
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
Salsitz E; Wiegand T
J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
[TBL] [Abstract][Full Text] [Related]
6. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
[TBL] [Abstract][Full Text] [Related]
7. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
8. Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
Pro G; Utter J; Haberstroh S; Baldwin JA
Drug Alcohol Depend; 2020 Apr; 209():107952. PubMed ID: 32172130
[TBL] [Abstract][Full Text] [Related]
9. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
[TBL] [Abstract][Full Text] [Related]
10. Opioid substitution treatment in New Zealand: a 40 year perspective.
Deering D; Sellman JD; Adamson S
N Z Med J; 2014 Jul; 127(1397):57-66. PubMed ID: 24997702
[TBL] [Abstract][Full Text] [Related]
11. An overview on medication-assisted treatment (MAT) for opioid dependence.
Maiti T; Das S; Ramasamy A; Stanley Xavier A; Kumar Behera S; Selvarajan S
J Opioid Manag; 2020; 16(2):141-149. PubMed ID: 32329889
[TBL] [Abstract][Full Text] [Related]
12. Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review.
Feelemyer J; Des Jarlais D; Arasteh K; Abdul-Quader AS; Hagan H
Addiction; 2014 Jan; 109(1):20-32. PubMed ID: 23859638
[TBL] [Abstract][Full Text] [Related]
13. Introduction to the special issue on innovative interventions and approaches to expand medication assisted treatment: Seizing research opportunities made available by the opioid STR program.
Watson DP; Andraka-Christou B; Clarke T; Wiegandt J
J Subst Abuse Treat; 2020 Jan; 108():1-3. PubMed ID: 31668689
[TBL] [Abstract][Full Text] [Related]
14. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Medication-Assisted Treatment Options for Opioid Addiction: A Review of the Literature.
Spayde-Baker A; Patek J
J Addict Nurs; 2023 Oct-Dec 01; 34(4):E189-E194. PubMed ID: 34224485
[TBL] [Abstract][Full Text] [Related]
16. Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline.
Beauchamp GA; Hanisak JL; Amaducci AM; Koons AL; Laskosky J; Maron BM; McLoughlin TM
AANA J; 2022 Feb; 90(1):50-57. PubMed ID: 35076384
[TBL] [Abstract][Full Text] [Related]
17. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
White WL
J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
[TBL] [Abstract][Full Text] [Related]
18. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
Maglione MA; Raaen L; Chen C; Azhar G; Shahidinia N; Shen M; Maksabedian E; Shanman RM; Newberry S; Hempel S
J Subst Abuse Treat; 2018 Jun; 89():28-51. PubMed ID: 29706172
[TBL] [Abstract][Full Text] [Related]
19. A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective.
Kinsky S; Houck PR; Mayes K; Loveland D; Daley D; Schuster JM
J Subst Abuse Treat; 2019 Sep; 104():15-21. PubMed ID: 31370980
[TBL] [Abstract][Full Text] [Related]
20. Stigma from the Viewpoint of the Patient.
Woods JS; Joseph H
J Addict Dis; 2015; 34(2-3):238-47. PubMed ID: 26076048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
